EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A global federated real-world data and analytics platform for research

Matvey B Palchuk iD, Jack W London, David Perez-Rey, Zuzanna J Drebert, Jessamine P Winer-Jones iD, Courtney N Thompson, John Esposito, Brecht Claerhout

JAMIA Open · 06.04.2023 · 6 (2)

DOI: 10.1093/jamiaopen/ooad035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMIA Open, online erschienen am 13.05.2023. Verfasst von Matvey B Palchuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: TriNetX, LLC, Cambridge, Massachusetts, USA. Die Arbeit wurde bisher 900-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: TriNetX.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This article describes a scalable, performant, sustainable global network of electronic health record data for biomedical and clinical research. Materials and Methods TriNetX has created a technology platform characterized by a conservative security and governance model that facilitates collaboration and cooperation between industry participants, such as pharmaceutical companies and contract research organizations, and academic and community-based healthcare organizations (HCOs). HCOs participate on the network in return for access to a suite of analytics capabilities, large networks of de-identified data, and more sponsored trial opportunities. Industry participants provide the financial resources to support, expand, and improve the technology platform in return for access to network data, which provides increased efficiencies in clinical trial design and deployment.

Results

TriNetX is a growing global network, expanding from 55 HCOs and 7 countries in 2017 to over 220 HCOs and 30 countries in 2022. Over 19 000 sponsored clinical trial opportunities have been initiated through the TriNetX network. There have been over 350 peer-reviewed scientific publications based on the network’s data.

Conclusions

The continued growth of the TriNetX network and its yield of clinical trial collaborations and published studies indicates that this academic-industry structure is a safe, proven, sustainable path for building and maintaining research-centric data networks.

Schlagwörter

Stichwörter der Autor:innen

clinical trial protocolsdata managementdata warehouseelectronic health recordsreal-world data

Autor:innen und Institutionen

  • TriNetX, LLC, Cambridge, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Biomedical Informatics Group, Artificial Intelligence Department, Universidad Politécnica de Madrid, Madrid, Spain.

ORCID-Profile: Matvey B Palchuk, Jessamine P Winer-Jones

Förderung

  • TriNetX

Zitieren

APA

Palchuk, M. B., London, J. W., Perez-Rey, D., Drebert, Z. J., Winer-Jones, J. P., Thompson, C. N., Esposito, J., & Claerhout, B. (2023). A global federated real-world data and analytics platform for research. JAMIA Open, 6(2). https://doi.org/10.1093/jamiaopen/ooad035

Vancouver

Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2). doi:10.1093/jamiaopen/ooad035

BibTeX
@article{Palchuk2023,
  author = {Palchuk, Matvey B and London, Jack W and Perez-Rey, David and Drebert, Zuzanna J and Winer-Jones, Jessamine P and Thompson, Courtney N and Esposito, John and Claerhout, Brecht},
  title = {A global federated real-world data and analytics platform for research},
  journal = {JAMIA Open},
  year = {2023},
  volume = {6},
  number = {2},
  doi = {10.1093/jamiaopen/ooad035}
}
Kostenlos starten →